Endovia Health Sciences, Inc. (EDVA)
NYSEAMERICAN: EDVA · Real-Time Price · USD
0.3098
-0.0102 (-3.19%)
Aug 28, 2026, 4:00 PM EDT - Market closed
Endovia Health Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.03 | 0.07 | 0.8 | 18.85 | 18.09 | 11.32 | |
Revenue Growth | - | -90.88% | -95.75% | 4.22% | 59.84% | 391.97% |
Cost of Revenue | 0.49 | 0.51 | 0.92 | 13.28 | 12.17 | 7.4 |
Gross Profit | -0.45 | -0.43 | -0.12 | 5.57 | 5.92 | 3.92 |
Selling, General & Admin | 4.32 | 5.58 | 7.42 | 19.69 | 19.9 | 14.61 |
Operating Expenses | 14.04 | 14.2 | 9.78 | 20.86 | 27.31 | 33 |
Operating Income | -14.49 | -14.64 | -9.9 | -15.29 | -21.39 | -29.08 |
Interest Expense | -2.6 | -4.37 | -7.38 | -5.69 | -0.25 | -0.44 |
Interest & Investment Income | 0 | - | 0 | 0 | 0.01 | 0 |
Other Non Operating Income (Expenses) | 0.52 | 0.21 | -0 | -0.03 | - | 0 |
EBT Excluding Unusual Items | -16.57 | -18.79 | -17.28 | -21 | -21.64 | -29.52 |
Legal Settlements | - | - | -0.33 | - | - | - |
Other Unusual Items | 0.04 | -5.56 | - | - | - | 0.18 |
Pretax Income | -16.86 | -24.35 | -17.61 | -21 | -21.64 | -29.35 |
Earnings From Continuing Operations | -16.86 | -24.35 | -17.61 | -21 | -21.64 | -29.35 |
Earnings From Discontinued Operations | -0.43 | -0.89 | -6.15 | - | -0.05 | 0.29 |
Net Income to Company | - | -25.23 | -23.76 | -21 | -21.69 | -29.05 |
Net Income | -17.28 | -25.23 | -23.76 | -21 | -21.69 | -29.05 |
Preferred Dividends & Other Adjustments | 1.55 | 0.83 | - | - | - | - |
Net Income to Common | -18.84 | -26.07 | -23.76 | -21 | -21.69 | -29.05 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 1 | 1 | 0 | 0 | 0 | 0 |
Shares Outstanding (Diluted) | 1 | 1 | 0 | 0 | 0 | 0 |
Shares Change | 236.95% | 62.76% | 26.12% | 13.53% | 29.38% | 55.89% |
EPS (Basic) | -13.60 | -47.86 | -71.00 | -79.17 | -92.82 | -160.83 |
EPS (Diluted) | -13.60 | -47.86 | -71.00 | -79.17 | -92.82 | -160.83 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -5.41 | -4.79 | -7.8 | -10.2 | -14.18 | -15.21 |
Free Cash Flow Per Share | -3.90 | -8.79 | -23.30 | -38.46 | -60.66 | -84.22 |
Gross Margin | - | - | -14.95% | 29.54% | 32.72% | 34.62% |
Operating Margin | -45159.07% | -20030.42% | -1235.59% | -81.10% | -118.28% | -257.01% |
Profit Margin | -58697.10% | -35675.66% | -2964.85% | -111.42% | -119.92% | -256.72% |
Free Cash Flow Margin | -16849.21% | -6554.54% | -972.94% | -54.13% | -78.38% | -134.44% |
EBITDA | -14.48 | -14.63 | -9.5 | -14.74 | -20.46 | -28.97 |
EBITDA Margin | - | - | - | -78.20% | -113.11% | -256.02% |
D&A For EBITDA | 0.01 | 0.01 | 0.4 | 0.55 | 0.94 | 0.11 |
EBIT | -14.49 | -14.64 | -9.9 | -15.29 | -21.39 | -29.08 |
EBIT Margin | - | - | - | -81.10% | -118.28% | -257.01% |
Advertising Expenses | - | 0.06 | 0.49 | 1.72 | 0.73 | 0.73 |